Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Biolife Solutions Inc. (BLFS:NASDAQ), powered by AI.
Biolife Solutions Inc. is currently trading at $26.10. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Biolife Solutions Inc. on Alpha Lenz.
View Biolife Solutions Inc.'s valuation metrics on Alpha Lenz.
“Biolife Solutions Inc.'s ROE is -1.3%. Explore profitability and growth together.”
Ask for details →Biolife Solutions Inc. is a leading provider of cell and gene therapy bioproduction tools and services. It specializes in offering biopreservation media, automated thawing devices, and storage solutions that are essential for preserving and transporting biological materials. The company's products help enhance the quality and stability of biological samples, which is crucial in sectors like regenerative medicine, biobanking, and drug discovery. By ensuring the safe handling and preservation of cells, tissues, and organs, Biolife Solutions plays a pivotal role in supporting life science research and clinical applications. The company's innovations contribute significantly to advancing therapeutic research and the development of treatments, thereby impacting the healthcare industry extensively. Headquartered in Bothell, Washington, Biolife Solutions Inc. is strategically positioned in the market, facilitating the evolving needs of the biopharmaceutical sector worldwide.
“Biolife Solutions Inc.'s ROE is -1.3%. Explore profitability and growth together.”
Ask for details →Biolife Solutions Inc. (ticker: BLFS) is a company listed on NASDAQ in the Healthcare sector (Medical Instruments & Supplies). It has approximately 159 employees.
The current price is $26.1 with a P/E ratio of -x and P/B of -x.
ROE is -1.27% and operating margin is -17.26%. Annual revenue is $96M.